From October 1, 2022 to December 31, 2022, the company has repurchased 411,761 shares, representing 1.22% for $7.64 million. With this, the company has completed the repurchase of 3,235,823 shares, representing 9.34% for $61.88 million under the buyback announced on August 16, 2021.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.88 USD | +0.33% | +1.07% | +3.96% |
07-01 | Collegium Pharmaceutical, Inc.(NasdaqGS:COLL) added to Russell 2000 Growth-Defensive Index | CI |
07-01 | Collegium Pharmaceutical, Inc.(NasdaqGS:COLL) added to Russell 2000 Defensive Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.96% | 1.04B | |
+61.97% | 856B | |
+38.95% | 631B | |
-3.92% | 359B | |
+15.27% | 325B | |
+9.03% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.86% | 177B | |
+2.21% | 165B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Tranche Update on Collegium Pharmaceutical, Inc.'s Equity Buyback Plan announced on August 16, 2021.